FDA has issued a new guidance document “FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic”
“FDA is issuing this guidance to provide general considerations to assist sponsors in assuring the
safety of trial participants, maintaining compliance with good clinical practice (GCP), and
minimizing risks to trial integrity during the COVID-19 pandemic.”